MicroRNA-217: a therapeutic and diagnostic tumor marker

Introduction Cancer as one of the most common causes of death has always been one of the major health challenges globally. Since, the identification of tumors in the early tumor stages can significantly reduce mortality rates; it is required to introduce novel early detection tumor markers. MicroRNAs (miRNAs) have pivotal roles in regulation of cell proliferation, migration, apoptosis, and tumor progression. Moreover, due to the higher stability of miRNAs than mRNAs in body fluids, they can be considered as non-invasive diagnostic or prognostic markers in cancer patients. Areas covered In the present review we have summarized the role of miR-217 during tumor progressions. The miR-217 functions were categorized based on its target molecular mechanisms and signaling pathways. Expert Opinion It was observed that miR-217 mainly exerts its function by regulation of the transcription factors during tumor progressions. The WNT, MAPK, and PI3K/AKT signaling pathways were also important molecular targets of miR-217 in different cancers. The present review clarifies the molecular biology of miR-217 and paves the way of introducing miR-217 as a non-invasive diagnostic marker and therapeutic target in cancer therapy.

Automated summary

Cancer is a major global health challenge, and early detection of tumors is crucial for reducing mortality rates. MicroRNAs, particularly miR-217, play key roles in cell regulation and can serve as non-invasive diagnostic markers in cancer patients. miR-217 functions by regulating transcription factors and targeting important signaling pathways in various cancers, making it a promising therapeutic target in cancer therapy.